These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Jonathan K. C. Knowles discusses the impact of pharmacogenomics on market segmentation. Knowles JK Nat Rev Drug Discov; 2004 Oct; 3(10):822. PubMed ID: 15497246 [No Abstract] [Full Text] [Related]
5. The long and winding road. Nat Rev Drug Discov; 2005 Jun; 4(6):443. PubMed ID: 15959946 [No Abstract] [Full Text] [Related]
6. Wisdom of the crowd. Nature; 2005 Nov; 438(7066):281. PubMed ID: 16292279 [No Abstract] [Full Text] [Related]
7. Following the script: how drug reps make friends and influence doctors. Fugh-Berman A; Ahari S PLoS Med; 2007 Apr; 4(4):e150. PubMed ID: 17455991 [TBL] [Abstract][Full Text] [Related]
8. The marketplace can't give us the drug safety data we need. Avorn J MedGenMed; 2007 Feb; 9(1):29. PubMed ID: 17435636 [No Abstract] [Full Text] [Related]
9. Price check! An analysis of direct-to-consumer pharmaceutical marketing. Wakeam E Acad Med; 2009 Feb; 84(2):234-5. PubMed ID: 19174677 [No Abstract] [Full Text] [Related]
10. MMA supports Gov. Pawlenty's call for study of drug-marketing costs. Minn Med; 2006 Aug; 89(8):23. PubMed ID: 16967878 [No Abstract] [Full Text] [Related]
11. Perception of prescription medicine sample packs among Australian professional, government, industry, and consumer organizations, based on automated textual analysis of one-on-one interviews. Kyle GJ; Nissen L; Tett S Clin Ther; 2008 Dec; 30(12):2461-73. PubMed ID: 19167604 [TBL] [Abstract][Full Text] [Related]
12. Research & market strategy: how choice of drug discovery approach can affect market position. Sams-Dodd F Drug Discov Today; 2007 Apr; 12(7-8):314-8. PubMed ID: 17395091 [TBL] [Abstract][Full Text] [Related]
13. Companies line up for hereditary angioedema market. Huggett B Nat Biotechnol; 2008 Apr; 26(4):364-5. PubMed ID: 18392002 [No Abstract] [Full Text] [Related]
14. [Commercial effectiveness of the pharmaceutical industry. Industry cost-effectiveness and customers value]. Mur Martà J; Vilardell Molas M Med Clin (Barc); 2004 May; 122(19):753-7. PubMed ID: 15171911 [No Abstract] [Full Text] [Related]
16. Designs that enrich lives. Link A; Stark H Arch Pharm (Weinheim); 2007 Oct; 340(10):509-10. PubMed ID: 17912676 [No Abstract] [Full Text] [Related]
17. Keeping the door open to pharma. Harris J Fam Pract Manag; 2009; 16(4):10. PubMed ID: 19630169 [No Abstract] [Full Text] [Related]
18. Biotech jostles with pharma for slice of HIV market. Katsnelson A Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375 [No Abstract] [Full Text] [Related]
19. A change in the market--investing in diagnostics. Batchelder K; Miller P Nat Biotechnol; 2006 Aug; 24(8):922-6. PubMed ID: 16900131 [No Abstract] [Full Text] [Related]
20. The pharmaceutical industry and the medical profession. Phatak A Issues Med Ethics; 1998; 6(4):131-2. PubMed ID: 16267942 [No Abstract] [Full Text] [Related] [Next] [New Search]